Use of Disposable Stethoscope Covers for Reduction of Stethoscope MRSA Contamination
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- NYU Langone Health
- Enrollment
- 1
- Locations
- 1
- Primary Endpoint
- MRSA colony count cultured from stethoscope diaphragms
Study Overview
Brief Summary
This is a prospective pilot study using a randomized, controlled, single blinded, crossover trial design, evaluating the effect of daily antimicrobial stethoscope diaphragm covers versus uncovered stethoscope. Stethoscopes will be cleaned Sani-cloth germicidal disposable wipes which are effective against MRSA. Each participant will then be randomly assigned to 7 days in either the intervention or the control arm. At the end of the 7 days participants stethoscopes will be cleaned again. This will be followed by another 7 days in the arm that they are not in during the first 7 days.
The primary endpoint is MRSA colony count from stethoscope diaphragms cultures at 7 days, focusing on the difference between the intervention and the control periods. The secondary endpoint is the rate of hospital acquired MRSA infection in patients treated by residents during each period.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Prevention
- Masking
- None
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Internal Medicine Residents
Exclusion Criteria
- Not provided
Arms & Interventions
Antimicrobial Stethoscope Diaphragm Covers
Intervention: Daily Antimicrobial Stethoscope Diaphragm Cover (Other)
Antimicrobial Stethoscope Diaphragm Covers
Intervention: Uncovered Stethoscopes (Other)
Uncovered Stethoscopes
Intervention: Daily Antimicrobial Stethoscope Diaphragm Cover (Other)
Uncovered Stethoscopes
Intervention: Uncovered Stethoscopes (Other)
Outcomes
Primary Outcomes
MRSA colony count cultured from stethoscope diaphragms
Time Frame: 7 Days
Total CFU of each selected pathogen at 7 days compared by paired Mann-Whitney U tests, with each patient serving as their own control
Secondary Outcomes
- Rate of hospital acquired MRSA infection in patients treated by participating residents(14 Days)